<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02372747</url>
  </required_header>
  <id_info>
    <org_study_id>2013-179</org_study_id>
    <nct_id>NCT02372747</nct_id>
  </id_info>
  <brief_title>Comparison of Delta-Shaped and Billroth II After TLDG</brief_title>
  <acronym>TLDG</acronym>
  <official_title>Comparison of Delta-Shaped and Billroth II for Intracorporeal Anastomosis After Totally Laparoscopic Distal Gastrectomy for Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Hospital of Jilin University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the safety and feasibility of Delta-shaped anastomosis and Billroth II anastomosis
      after totally laparoscopic distal gastrectomy for gastric cancer(TLDG).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods: 78 consecutive patients who underwent TLDG in First Hospital of Jilin University
      between October 2012 and December 2014 were enrolled in this study . All patients were
      divided randomly into two groups:Delta-shaped anastomosis group (DS group) and Billroth II
      anastomosis group (B-II group), and the patients in DS group underwent Delta-shaped
      anastomosis after TLDG, and the patients in B-II group underwent Billroth-II anastomosis
      after TLDG.Outcome measures,resected margin,operative time,anastomosis time,number of stapler
      cartridges used,length of the incision,the time of first flatus and liquid diet,hospital stay
      and postoperative morbidity are compared between the two groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stage distribution</measure>
    <time_frame>up to 7 days after the operation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Resected margin</measure>
    <time_frame>up to 7 days after the operation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Operative time</measure>
    <time_frame>up to 7 days after the operation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Anastomosis time</measure>
    <time_frame>up to 7 days after the operation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The number of stapler cartridges used</measure>
    <time_frame>up to 7 days after the operation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Median estimated blood loss</measure>
    <time_frame>up to 7 days after the operation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Red blood cell transfusion</measure>
    <time_frame>up to 7 days after the operation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of the incision</measure>
    <time_frame>up to 7 days after the operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative complication</measure>
    <time_frame>up to 30 days after the operation</time_frame>
    <description>Major complications includes anastomosis leakage and intrabdominal bleeding . Minor complications includes bile regurgitation,anastomotic stenosis and delayed gastric emptying.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">78</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Delta-shaped anastomosis group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients in DS group underwent Delta-shaped anastomosis after TLDG.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Billroth II anastomosis group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients in B-II group underwent Billroth-II anastomosis after TLDG.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Delta-shaped anastomosis</intervention_name>
    <description>The patients in DS group underwent Delta-shaped anastomosis after TLDG.</description>
    <arm_group_label>Delta-shaped anastomosis group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Billroth II anastomosis</intervention_name>
    <description>The patients in B-II group underwent Billroth-II anastomosis after TLDG.</description>
    <arm_group_label>Billroth II anastomosis group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  carcinoma located in the lower 1/3 of gastric body or antrum of stomach

          -  diagnosed by endoscopy ,endoscopic ultrasonography and abdominal CT scan

          -  diameter of the tumor &lt;3cm

          -  no pyloric obstruction

        Exclusion Criteria:

          -  diameter of the tumor â‰¥3cm

          -  associated with obstruction, bleeding, emergency surgery or surgical intervention

          -  tumor with extensive metastasis

          -  patient had previously undergone gastrostomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Quan Wang, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>First Hospital of Jilin University</affiliation>
  </overall_official>
  <verification_date>February 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2015</study_first_submitted>
  <study_first_submitted_qc>February 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2015</study_first_posted>
  <last_update_submitted>February 21, 2015</last_update_submitted>
  <last_update_submitted_qc>February 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Hospital of Jilin University</investigator_affiliation>
    <investigator_full_name>Quan Wang</investigator_full_name>
    <investigator_title>Deputy Director of General Surgery</investigator_title>
  </responsible_party>
  <keyword>Totally laparoscopic gastrectomy</keyword>
  <keyword>laparoscopic distal gastrectomy</keyword>
  <keyword>Intracorporeal anastomosis</keyword>
  <keyword>Delta-Shaped Anastomosis</keyword>
  <keyword>Billroth II Anastomosis</keyword>
  <keyword>Gastric cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

